Showing 1 - 10 of 113
The Yunus Centre for Social Business & Health was opened by Nobel Peace Laureate, Professor Muhammad Yunus, in June 2010. In short, the Centre aims to build a research portfolio in the broad area of "social business as a public health intervention", thus working on the cutting edges of (and...
Persistent link: https://www.econbiz.de/10010934772
Resources available to the health care sector are finite and typically insufficient to fulfil all the demands for health care in the population. Decisions must be made about which treatments to provide. Relatively little is known about the views of the general public regarding the principles...
Persistent link: https://www.econbiz.de/10011189693
<section xml:id="hec3018-sec-0001" numbered="no"> Background</title> The appropriate thresholds for decisions on the cost‐effectiveness of medical interventions remain controversial, especially in ‘end‐of‐life’ situations. Evidence of the values placed on different types of health gain by the general public is limited.</section> <section xml:id="hec3018-sec-0002" numbered="no"> <title type="main">Methods</title> Across nine...</section>
Persistent link: https://www.econbiz.de/10011160873
ABSTRACT The elicitation of societal views about healthcare priority setting is an important, contemporary research area, and there are a number of studies that apply either qualitative techniques or quantitative preference elicitation methods. However, there are methodological challenges in...
Persistent link: https://www.econbiz.de/10011005341
Recently, for many health economics researchers, empirical estimation of the monetary valuation of a quality-adjusted life year (QALY) has become an important endeavour. Different philosophical and practical approaches to this have emerged. On the one hand, there is a view that, with health-care...
Persistent link: https://www.econbiz.de/10009292048
Persistent link: https://www.econbiz.de/10005404919
We provided more evidence on the functional relationship between willingness to pay for risk reductions and age (the senior discount). We overcome many of the limitations of previous literature that has dealt with this problem, namely, the influence of the assumptions used in statistical models...
Persistent link: https://www.econbiz.de/10010900640
The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50...
Persistent link: https://www.econbiz.de/10011177459
This comprehensive collection brings together more than 50 contributions from some of the most influential researchers in health economics. It authoritatively covers theoretical and empirical issues in health economics, with a balanced range of material on equity and efficiency in health care...
Persistent link: https://www.econbiz.de/10011179923
Debate about the monetary value of a quality-adjusted life year (QALY) has existed in the health economics literature for some time. More recently, concern about such a value has arisen in UK health policy. This paper reports on an attempt to 'model' a willingness-to-pay-based value of a QALY...
Persistent link: https://www.econbiz.de/10004964425